|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.24 CNY | -0.36% |
|
-5.32% | -17.99% |
| 20/06 | Nhwa Pharmaceutical's Penehyclidine Hydrochloride Injection Passes Regulatory Testing | MT |
| 20/06 | Nhwa Pharmaceutical Gets Registration Certificate for Pregabalin Capsules | MT |
Jiangsu Nhwa Pharmaceutical Co., Ltd. (SZSE:002262) announced that a Xuzhou-based investment firm plans to reduce stake in the company to no less than 35.09% from 40.09%.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.99% | 3.1B | |
| +61.53% | 856B | |
| +38.95% | 631B | |
| -3.66% | 359B | |
| +15.06% | 325B | |
| +9.18% | 297B | |
| +5.89% | 234B | |
| +16.53% | 226B | |
| +15.67% | 177B | |
| +2.47% | 165B |
JIANGSU NHWA PHARMACEUTICAL CO., LTD 
